Stockscreener 앱 받기
3.404
1.90%
-0.066
전일 마감가:
$3.47
열려 있는:
$3.53
하루 거래량:
223.48K
Relative Volume:
0.29
시가총액:
$652.15M
수익:
$12.99M
순이익/손실:
$-74.39M
주가수익비율:
-7.7364
EPS:
-0.44
순현금흐름:
$-78.92M
1주 성능:
+3.78%
1개월 성능:
+8.41%
6개월 성능:
-0.76%
1년 성능:
-3.02%
1일 변동 폭
$3.38
$3.54
1주일 범위
$3.26
$3.55
52주 변동 폭
$2.705
$4.725
Arbutus Biopharma Corp Stock (ABUS) Company Profile
명칭
Arbutus Biopharma Corp
전화
604-419-3200
주소
701 VETERANS CIRCLE, WARMINSTER, PA
ABUS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
3.405 | 653.11M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.78 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.99 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.97 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.10 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.30 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-02-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-25 | 개시 | Jefferies | Hold |
| 2020-12-17 | 개시 | H.C. Wainwright | Buy |
| 2020-07-27 | 재개 | JMP Securities | Mkt Outperform |
| 2020-07-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-03-06 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | 개시 | Robert W. Baird | Outperform |
| 2020-02-05 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | 재확인 | B. Riley FBR | Buy |
| 2019-10-04 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | 업그레이드 | Wedbush | Underperform → Neutral |
| 2018-10-12 | 재확인 | Chardan Capital Markets | Buy |
| 2018-07-06 | 다운그레이드 | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | 재개 | Chardan Capital Markets | Buy |
| 2018-03-19 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | 재확인 | Wedbush | Outperform |
| 2016-12-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
모두보기
Arbutus Biopharma Corp 주식(ABUS)의 최신 뉴스
Arbutus Biopharma Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Arbutus Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
Arbutus Biopharma Reports Q2 Earnings of $2.523mln, Revenue of $10.739mln, EPS of $0.01 - AInvest
Arbutus: Q2 Earnings Snapshot - WFMJ.com
Arbutus Biopharma Corp Reports Q2 2025 Earnings: EPS of $0.01 an - GuruFocus
Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Real time social sentiment graph for Arbutus Biopharma CorporationHigh Return Strategy with Low Risk - Newser
Arbutus Biopharma (ABUS) Projected to Post Earnings on Thursday - Defense World
Forecasting Arbutus Biopharma Corporation price range with options dataTriple Digit Gain Opportunity Watchlist - Newser
Is Arbutus Biopharma Corporation stock reversal real or fakeAI Trend Detection for Entry Timing - Newser
What risks could impact Arbutus Biopharma Corporation stock performanceInstitutional Holding Behavior Pattern Analysis - Newser
Arbutus Biopharma Corporation stock trendline breakdownMarket Timing Strategy with Technical Filters - Newser
Applying big data sentiment scoring on Arbutus Biopharma CorporationWeekly Price Target Forecast and Alerts - Newser
When is the best time to buy Arbutus Biopharma Corporation stockSafe Entry Strategy with High Win Rate - Newser
What are the latest earnings results for Arbutus Biopharma CorporationBuild a diversified portfolio for steady growth - Jammu Links News
What are the technical indicators suggesting about Arbutus Biopharma CorporationTriple-digit returns - Jammu Links News
What data driven models say about Arbutus Biopharma Corporation’s futureShort Term High Yield Stock Tips for Active Traders - beatles.ru
Bank of New York Mellon Corp Decreases Holdings in Arbutus Biopharma Corporation (NASDAQ:ABUS) - Defense World
Why Arbutus Biopharma Corporation stock attracts strong analyst attentionFree AI Trading Suggestions With Accuracy Focus - Newser
Is now a turning point for Arbutus Biopharma CorporationWeekly Portfolio Update with ROI Focus - Newser
Technical analysis overview for Arbutus Biopharma Corporation stockFree Buy Low Sell High Stock Watch - Newser
Arbutus Biopharma Corporation Recovery Hinges on Volume BreakoutSecure Return Focused Investment Plan Released - metal.it
Published on: 2025-07-30 00:59:28 - Newser
Will breakout in Arbutus Biopharma Corporation lead to full recoveryFree Reliable Chart-Based Trade Entries - Newser
Published on: 2025-07-28 23:59:46 - beatles.ru
What catalysts could drive Arbutus Biopharma Corporation stock higher in 2025Consistently exceptional gains - Jammu Links News
Arbutus Biopharma Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
Does Arbutus Biopharma Corporation stock perform well during market downturnsRapid market gains - jammulinksnews.com
When is Arbutus Biopharma Corporation stock expected to show significant growthConsistent triple returns - Jammu Links News
How strong is Arbutus Biopharma Corporation company’s balance sheetInvest in stocks with strong fundamentals - Jammu Links News
What institutional investors are buying Arbutus Biopharma Corporation stockDiscover stocks with massive upside potential - Jammu Links News
Published on: 2025-07-28 03:47:36 - jammulinksnews.com
Is Arbutus Biopharma Corporation Stock a Smart Buy in 2025 Investment Analysis InsideVerified Return Tips - Newser
How Arbutus Biopharma Corporation stock performs during market volatilityFree Stock Investment Growth Plan - Newser
Is Arbutus Biopharma Corporation a good long term investmentMassive wealth growth - PrintWeekIndia
What analysts say about Arbutus Biopharma Corporation stockSuperior returns - jammulinksnews.com
Arbutus Biopharma Corporation (NASDAQ:ABUS) Position Cut by Teacher Retirement System of Texas - Defense World
What drives Arbutus Biopharma Corporation stock priceSuperior stock growth - Autocar Professional
Arbutus Biopharma Corporation Stock Analysis and ForecastDynamic profit opportunities - jammulinksnews.com
What makes Arbutus Biopharma Corporation stock price move sharplyFree Deep Market Trend Analysis - Newser
Arbutus Biopharma Corp (ABUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
2.25%
자본화:
|
볼륨(24시간):